Biomarin Pharmaceutical Inc (BMRN)
80.94
-1.23
(-1.50%)
USD |
NASDAQ |
Apr 26, 16:00
82.00
+1.06
(+1.31%)
After-Hours: 20:00
Biomarin Pharmaceutical Cash from Operations (Quarterly): 27.48M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.48M |
| September 30, 2023 | 135.65M |
| June 30, 2023 | 70.06M |
| March 31, 2023 | -73.93M |
| December 31, 2022 | 6.786M |
| September 30, 2022 | 158.32M |
| June 30, 2022 | 56.23M |
| March 31, 2022 | -45.43M |
| December 31, 2021 | 11.18M |
| September 30, 2021 | 97.06M |
| June 30, 2021 | 82.78M |
| March 31, 2021 | 113.51M |
| December 31, 2020 | -13.38M |
| September 30, 2020 | 86.21M |
| June 30, 2020 | 27.74M |
| March 31, 2020 | -15.19M |
| December 31, 2019 | 57.34M |
| September 30, 2019 | 70.12M |
| June 30, 2019 | -24.34M |
| March 31, 2019 | -54.87M |
| December 31, 2018 | 49.37M |
| September 30, 2018 | 47.20M |
| June 30, 2018 | -33.86M |
| March 31, 2018 | -42.51M |
| December 31, 2017 | 14.61M |
| Date | Value |
|---|---|
| September 30, 2017 | 38.29M |
| June 30, 2017 | 18.78M |
| March 31, 2017 | -80.44M |
| December 31, 2016 | -0.21M |
| September 30, 2016 | -10.37M |
| June 30, 2016 | -45.80M |
| March 31, 2016 | -171.45M |
| December 31, 2015 | -65.85M |
| September 30, 2015 | -2.85M |
| June 30, 2015 | -12.99M |
| March 31, 2015 | -137.81M |
| December 31, 2014 | -23.91M |
| September 30, 2014 | -8.557M |
| June 30, 2014 | -11.46M |
| March 31, 2014 | -26.49M |
| December 31, 2013 | -8.997M |
| September 30, 2013 | -9.492M |
| June 30, 2013 | -6.817M |
| March 31, 2013 | -32.03M |
| December 31, 2012 | 11.99M |
| September 30, 2012 | 14.21M |
| June 30, 2012 | -1.42M |
| March 31, 2012 | -7.171M |
| December 31, 2011 | -0.513M |
| September 30, 2011 | 8.861M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-73.93M
Minimum
Mar 2023
158.32M
Maximum
Sep 2022
43.59M
Average
56.23M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Pfizer Inc | 5.24B |
| Eli Lilly and Co | -311.90M |
| Merck & Co Inc | 246.00M |
| Bristol-Myers Squibb Co | 4.252B |
| Moderna Inc | 622.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -64.96M |
| Cash from Financing (Quarterly) | 10.84M |
| Free Cash Flow | 51.65M |
| Free Cash Flow Per Share (Quarterly) | -0.0489 |
| Free Cash Flow to Equity (Quarterly) | -10.20M |
| Free Cash Flow to Firm (Quarterly) | -9.213M |
| Free Cash Flow Yield | 0.33% |